Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

By afschroeder • February 20, 2026

Ahmed M, Zulfiqar E, Hashmi TM, Zia R, Ashraf H, Naveed MA, Ahmed R, Rana JS, Ahmed F, Greene SJ, Fudim M, Mentz RJ, Fonarow GC. Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. ESC Heart Fail. 2026 Feb 3;13(1):xvaf018. doi: 10.1093/eschf/xvaf018. PMID: 41711738.

Tags: Cardiology/Epi, Ferric carboxymaltose, heart failure, iron deficiency, meta-analysis, Publications

Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry

Zhang S, Raman VK, Shao Y, Patel S, Cheng Y, Workman TE, Sheriff HM, Fonarow GC, Lam PH, Heidenreich PA, Morgan CJ, Moore HJ, Vargas[...]

Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National Survey

Silver E, Punt M, Wang J, Brann A, Khedraki R, Kumar S, Duran A, Greenberg B, Hong KN, Bui QM. Cardiology Provider Knowledge and Attitudes[...]

Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis

Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and[...]